Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

TRVI

Trevi Therapeutics, Inc.

CIK 0001563880 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$17.96
↓ 0.29 (-1.59%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals, Options; Risks: Fundamentals

Key stats

Market Cap
$2.56B
P/E Ratio
-50.07
EPS
-0.32
Dividend Yield
Not covered
52W Position
83%
Beta
1.11

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
7.96
P/S
Not covered
EV/Revenue
Not covered
ROE
-15.9%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 83%
$6.93$20.22

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$42.76M
Total Assets
$193.44M
Free Cash Flow
-$42.10M

Recent news